Prof. Peter Kavsak
Professor Department of Pathology and Molecular Medicine, McMaster University Canada
Dr Carolyn Lam
Senior Consultant Cardiologist, Principal Lead of Clinical Trials & Trial Networks, National Heart Centre of Singapore
 

Latest IFCC Recommendations for Natriuretic Peptides in Heart Failure – Analytics and Clinical Considerations

Heart failure is a growing health and economic burden in ageing populations. Symptoms are often non-specific and do not help to discriminate between HF and other problems. Both B-type natriuretic peptide (BNP) and N-terminal pro-BNP (NT-proBNP) assist in making the diagnosis of HF and in determining its prognosis. In this webinar, you will learn the IFCC recommendations on the appropriate use, analytical performance, and gaps in clinical studies related to the use of natriuretic peptide (NP) assays.

Topics:

Appropriate use, analytical performance of Natriuretic Peptides assays

Clinical Aspects of Natriuretic Peptides with a Focus on Heart Failure

Why should you attend

Learning from sharing on the appropriate use, analytical performance, and gaps in clinical studies related to the use of natriuretic peptide (NP) assays

Learning from Clinician perspective on underlying biology of NP production and clearance in health and disease, as well as analytic issues that influence their clinical application, especially with regard to heart failure (HF)

Participate in Live Q&A session

Agenda:

President of APSC Cofound of digital trends in Asia

Updates from Leading Experts

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

Prof Alexandre Mebazaa shares the key results and highlights from the STRONG-HF study that assessed the safety, tolerability of optimization of guideline directed medical therapy.

28 March 2023
Prof Alexandre Mebazaa

CANVAS study: NT-proBNP and CVD risk reduction

Can you give us a short description of the CANVAS program? The CANVAS program was a set of two trials, whose goal was to evaluate the role of an SGLT2...

1 July 2021
Dr James L Januzzi